Open Meeting Announcement- MolDX: Minimal Residual Disease Testing for Cancer - October 28, 2020

This article has been published for notice under contract numbers: 02102 (AK), 02202 (ID), 02302 (OR), 02402 (WA), 03102 (AZ), 03202 (MT), 03302 (ND), 03402 (SD), 03502 (UT), and 03602 (WY).

Noridian will be hosting a Medicare Part A/B Open Meeting 2 p.m. to 4 p.m. CT. Wednesday,
October 28, 2020. Registration is required.

Proposed Local Coverage Determination (LCD) and Local Coverage Article (LCA)

  • LCD (DL38816): MolDX: Minimal Residual Disease Testing for Cancer
  • LCA (DA58456): Billing and Coding: MolDX: Minimal Residual Disease Testing for Cancer

View meeting details and register now from the Open Meeting webpage.

 

            Last Updated Thu, 01 Oct 2020 15:56:19 +0000